LRRK2 and membrane trafficking: nexus of Parkinson's disease

키워드

참고문헌 (68)

1. Abeliovich A, "Defects in trafficking bridge Parkinson's disease pathology and genetics", Nature, 539, pp.207~216 (2016)
2. Moss J, "A dopaminergic axon lattice in the striatum and its relationship with cortical and thalamic terminals", J Neurosci, 28, pp.11221~11230 (2008)
3. Matsuda W, "Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum", J Neurosci, 29, pp.444~453 (2009)
4. Paisan-Ruiz C, "Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease", Neuron, 44, pp.595~600 (2004)
5. Zimprich A, "Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology", Neuron, 44, pp.601~607 (2004)
6. Funayama M, "An LRRK2mutation as a cause for the parkinsonism in the original PARK8 family", Ann Neurol, 57, pp.918~921 (2005)
7. Nalls MA, "Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease", Nat Genet, 46, pp.989~993 (2014)
8. Lesage S, "G2019S LRRK2 mutation in french and north african families with Parkinson's disease", Ann Neurol, 58, pp.784~787 (2005)
9. Benamer HT, "LRRK2 G2019S in the North African population : a review", Eur Neurol, 63, pp.321~325 (2010)
10. Cookson MR, "The role of leucine-rich repeat kinase 2(LRRK2)in Parkinson's disease", Nat Rev Neurosci, 11, pp.791~797 (2010)
11. Paisan-Ruiz C, "LRRK2 : cause, risk, and mechanism", J Parkinsons Dis, 3, pp.85~103 (2013)
12. Wang X, "LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1", Hum Mol Genet, 21, pp.1931~1944 (2012)
13. Orenstein SJ, "Interplay of LRRK2 with chaperone-mediated autophagy", Nat Neurosci, 16, pp.394~406 (2013)
14. Parisiadou L, "Phosphorylation of ezrin", radixin, J Neurosci, pp.2009, 29[DOI]
15. Martin I, "Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease", Cell, 157, pp.472~485 (2014)
16. Trinh J, "Disease penetrance of late-onset parkinsonism : a meta-analysis", JAMA Neurol, 71, pp.1535~1539 (2014)
17. West AB, "Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity", Proc Natl Acad Sci U S A, 102, pp.16842~16847 (2005)
18. Greggio E, "Kinase activity is required for the toxic effects of mutant LRRK2", dardarin, 2006, pp.23, 329~341
19. Lee BD, "Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease", Nat Med, 16, pp.998~1000 (2010)
20. Smith WW, "Kinase activity of mutant LRRK2 mediates neuronal toxicity", Nat Neurosci, 9, pp.1231~1233 (2006)
21. West AB, "Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity", Hum Mol Genet, 16, pp.223~232 (2007)
22. Lee BD, "Leucine-rich repeat kinase 2(LRRK2)as a potential therapeutic target in Parkinson's disease", Trends Pharmacol Sci, 33, pp.365~373 (2012)
23. Biskup S, "Localization of LRRK2 to membranous and vesicular structures in mammalian brain", Ann Neurol, 60, pp.557~569 (2006)
24. Shin N, "LRRK2 regulates synaptic vesicle endocytosis", Exp Cell Res, 314, pp.2055~2065 (2008)
25. Piccoli G, "LRRK2controls synaptic vesicle storage and mobilization within the recycling pool", J Neurosci, 31, pp.2225~2237 (2011)
26. Alegre-Abarrategui J, "LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model", Hum Mol Genet, 18, pp.4022~4034 (2009)
27. Manzoni C, "Computational analysis of the LRRK2 interactome", PeerJ, 3, pp.e778~ (2015)
28. Tong Y, "Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice", Proc Natl Acad Sci U S A, 107, pp.9879~9884 (2010)
29. Dodson MW, "Roles of the Drosophila LRRK2 homolog in Rab7-dependent lysosomal positioning", Hum Mol Genet, 21, pp.1350~1363 (2012)
30. Stenmark H, "Rab GTPases as coordinators of vesicle traffic", Nat Rev Mol Cell Biol, 10, pp.513~525 (2009)
31. Hutagalung AH, "Role of Rab GTPases in membrane traffic and cell physiology", Physiol Rev, 91, pp.119~149 (2011)
32. Rivero-Rios P, "Alterations in late endocytic trafficking related to the pathobiology of LRRK2-linked Parkinson's disease", Biochem Soc Trans, 43, pp.390~395 (2015)
33. MacLeod DA, "RAB7L1interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk", Neuron, 77, pp.425~439 (2013)
34. Waschbusch D, "LRRK2 transport is regulated by its novel interacting partner Rab32", PLoS One, 9, pp.e111632~ (2014)
35. Beilina A, "Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease", Proc Natl Acad Sci U S A, 111, pp.2626~2631 (2014)
36. Gomez-Suaga P, "LRRK2delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab7 activity", Hum Mol Genet, 23, pp.6779~6796 (2014)
37. 허혜영, "Coordinate Regulation of Neurite Outgrowth by LRRK2 and Its Interactor, Rab5", Experimental Neurobiology, 19(2), pp.97~105 (2010), 한국뇌신경과학회
38. Jeong GR, "Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration", Mol Neurodegener, 13, pp.8~ (2018)
39. Steger M, "Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases", Elife, 5, pp.12813~ (2016)
40. Liu Z, "LRRK2phosphorylates membrane-bound Rabs and is activated by GTP-bound Rab7L1 to promote recruitment to the trans-Golgi network", Hum Mol Genet, 27, pp.385~395 (2018)
41. Steger M, "Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis", Elife, 6, pp.31012~ (2017)
42. Simon-Sanchez J, "Genome-wide association study reveals genetic risk underlying Parkinson's disease", Nat Genet, 41, pp.1308~1312 (2009)
43. Pihlstrom L, "Fine mapping and resequencing of the PARK16 locus in Parkinson's disease", J Hum Genet, 60, pp.357~362 (2015)
44. Purlyte E, "Rab29activation of the Parkinson's disease-associated LRRK2kinase", EMBO J, 37, pp.1~18 (2018)
45. Eguchi T, "LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis", Proc Natl Acad Sci U S A, 115, pp.E9115~E9124 (2018)[DOI]
46. Mazzulli JR, "alpha-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models", Proc Natl Acad Sci U S A, 113, pp.1931~1936 (2016)
47. Cooper AA, "Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models", Science, 313, pp.324~328 (2006)
48. Gitler AD, "The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis", Proc Natl Acad Sci U S A, 105, pp.145~150 (2008)
49. Dalfo E, "Abnormal alpha-synuclein interactions with Rab proteins in alpha-synuclein A30P transgenic mice", J Neuropathol Exp Neurol, 63, pp.302~313 (2004)
50. Saheki Y, "Synaptic vesicle endocytosis", Cold Spring Harb Perspect Biol, 4, pp.a005645~ (2012)
51. Matta S, "LRRK2controls an EndoA phosphorylation cycle in synaptic endocytosis", Neuron, 75, pp.1008~1021 (2012)
52. Gallop JL, "Mechanism of endophilin N-BAR domain-mediated membrane curvature", EMBO J, 25, pp.2898~2910 (2006)
53. Masuda M, "Endophilin BAR domain drives membrane curvature by two newly identified structure-based mechanisms", EMBO J, 25, pp.2889~2897 (2006)
54. Bai J, "Endophilin functions as a membrane-bending molecule and is delivered to endocytic zones by exocytosis", Cell, 143, pp.430~441 (2010)
55. Milosevic I, "Recruitment of endophilin to clathrin-coated pit necks is required for efficient vesicle uncoating after fission", Neuron, 72, pp.587~601 (2011)
56. Ambroso MR, "Endophilin A1 induces different membrane shapes using a conformational switch that is regulated by phosphorylation", Proc Natl Acad Sci U S A, 111, pp.6982~6987 (2014)
57. Hill E, "The role of dynamin and its binding partners in coated pit invagination and scission", J Cell Biol, 152, pp.309~323 (2001)
58. Verstreken P, "Synaptojanin is recruited by endophilin to promote synaptic vesicle uncoating", Neuron, 40, pp.733~748 (2003)
59. Islam MS, "Human R1441C LRRK2 regulates the synaptic vesicle proteome and phosphoproteome in a Drosophila model of Parkinson's disease", Hum Mol Genet, 25, pp.5365~5382 (2016)
60. Edvardson S, "A deleterious mutation in DNAJC6 encoding the neuronalspecific clathrin-uncoating co-chaperone auxilin, is associated with juvenile parkinsonism", PLoS One, 7, pp.e36458~ (2012)
61. Koroglu C, "DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability", Parkinsonism Relat Disord, 19, pp.320~324 (2013)
62. Nguyen M, "LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic neurons from patients with Parkinson's disease", Proc Natl Acad Sci U S A, 115, pp.5576~5581 (2018)
63. Belluzzi E, "LRRK2phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion(NSF)protein enhancing its ATPase activity and SNARE complex disassembling rate", Mol Neurodegener, 11, pp.1~ (2016)
64. Ryu JK, "Review : Progresses in understanding N-ethylmaleimide sensitive factor(NSF)mediated disassembly of SNARE complexes", Biopolymers, 105, pp.518~531 (2016)
65. Yu RC, "Structure of the ATP-dependent oligomerization domain of N-ethylmaleimide sensitive factor complexed with ATP", Nat Struct Biol, 5, pp.803~811 (1998)
66. 윤혜진, "LRRK2 phosphorylates Snapin and inhibits interaction of Snapin with SNAP-25", Experimental and Molecular Medicine, 45(8), pp.1~11 (2013), 생화학분자생물학회
67. Tian JH, "The role of Snapin in neurosecretion : snapin knock-out mice exhibit impaired calcium-dependent exocytosis of large dense-core vesicles in chromaffin cells", J Neurosci, 25, pp.10546~10555 (2005)
68. Shahmoradian SH, "Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes", Nat Neurosci, 22, pp.1099~1109 (2019)

관련 논문AI추천